大分子疗法
Macromolecular therapeutics.
作者信息
Yang Jiyuan, Kopeček Jindřich
机构信息
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City 84112, USA.
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City 84112, USA; Department of Bioengineering, University of Utah, Salt Lake City 84112, USA.
出版信息
J Control Release. 2014 Sep 28;190:288-303. doi: 10.1016/j.jconrel.2014.04.013. Epub 2014 Apr 18.
Abstract
This review covers water-soluble polymer-drug conjugates and macromolecules that possess biological activity without attached low molecular weight drugs. The main design principles of traditional and backbone degradable polymer-drug conjugates as well as the development of a new paradigm in nanomedicines - (low molecular weight) drug-free macromolecular therapeutics are discussed. To address the biological features of cancer, macromolecular therapeutics directed to stem/progenitor cells and the tumor microenvironment are deliberated. Finally, the future perspectives of the field are briefly debated.
摘要
本综述涵盖了水溶性聚合物-药物缀合物以及不连接低分子量药物但具有生物活性的大分子。讨论了传统的和主链可降解的聚合物-药物缀合物的主要设计原则，以及纳米医学新范式——（低分子量）无药物大分子疗法的发展。为了应对癌症的生物学特征，还探讨了针对干细胞/祖细胞和肿瘤微环境的大分子疗法。最后，简要讨论了该领域的未来前景。
相似文献
1
Macromolecular therapeutics.大分子疗法
J Control Release. 2014 Sep 28;190:288-303. doi: 10.1016/j.jconrel.2014.04.013. Epub 2014 Apr 18.
2
Polymer nanomedicines.聚合物纳米药物。
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
3
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.无药大分子疗法——聚合物纳米药物的新范例
Biomater Sci. 2015 Jul;3(7):908-22. doi: 10.1039/C4BM00442F.
4
Design of smart HPMA copolymer-based nanomedicines.基于聚甲基丙烯酸-N-羟丙酯共聚物的智能纳米药物设计。
J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3.
5
Polymer-drug conjugates: origins, progress to date and future directions.聚合物-药物偶联物：起源、至今的进展和未来方向。
Adv Drug Deliv Rev. 2013 Jan;65(1):49-59. doi: 10.1016/j.addr.2012.10.014. Epub 2012 Nov 2.
6
Cancer-targeted polymeric drugs.癌症靶向聚合物药物。
Curr Cancer Drug Targets. 2002 Sep;2(3):209-26. doi: 10.2174/1568009023333836.
7
POLYMERIC BIOMATERIALS AND NANOMEDICINES.高分子生物材料与纳米药物
J Drug Deliv Sci Technol. 2015 Dec 1;30(Pt B):318-330. doi: 10.1016/j.jddst.2015.05.012.
8
Polymer therapeutics: concepts and applications.聚合物疗法：概念与应用
Angew Chem Int Ed Engl. 2006 Feb 13;45(8):1198-215. doi: 10.1002/anie.200502113.
9
Polymer-drug conjugates: present state of play and future perspectives.聚合物-药物偶联物：现状与未来展望
Drug Discov Today. 2013 Dec;18(23-24):1316-22. doi: 10.1016/j.drudis.2013.09.007. Epub 2013 Sep 17.
10
HPMA copolymers: origins, early developments, present, and future.HPMA 共聚物：起源、早期发展、现状和未来。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):122-49. doi: 10.1016/j.addr.2009.10.004. Epub 2009 Nov 14.
引用本文的文献
1
Resistance mechanisms of non-small cell lung cancer and improvement of treatment effects through nanotechnology: a narrative review.非小细胞肺癌的耐药机制及通过纳米技术改善治疗效果：一篇叙述性综述
J Thorac Dis. 2024 Nov 30;16(11):8039-8052. doi: 10.21037/jtd-24-1078. Epub 2024 Nov 15.
2
GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine.谷胱甘肽敏感型聚合物前药：作为纳米级化学 - 光动力抗癌纳米药物的合成及光敏剂负载
Acta Pharm Sin B. 2022 Jan;12(1):424-436. doi: 10.1016/j.apsb.2021.05.003. Epub 2021 May 15.
3
PEGylated Oligothioetheramide Prodrugs Activated by Host Serum Proteases.聚乙二醇化寡硫醚酰胺前药，经宿主血清蛋白酶激活。
Chembiochem. 2021 Sep 2;22(17):2697-2702. doi: 10.1002/cbic.202100146. Epub 2021 Jul 13.
4
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery.基于聚甲基丙烯酸羟乙酯共聚物的纳米药物用于可控药物递送
J Pers Med. 2021 Feb 10;11(2):115. doi: 10.3390/jpm11020115.
5
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.用于呼吸系统疾病的靶向纳米疗法：癌症、纤维化和冠状病毒。
Adv Ther (Weinh). 2021 Feb;4(2):2000203. doi: 10.1002/adtp.202000203. Epub 2020 Oct 13.
6
Telodendrimer-Based Macromolecular Drug Design using 1,3-Dipolar Cycloaddition for Applications in Biology.基于树状大分子的 1,3-偶极环加成在生物医学中的应用的大分子药物设计
Molecules. 2020 Feb 15;25(4):857. doi: 10.3390/molecules25040857.
7
Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron.用于排泄过量全身毒性铁的安全纳米治疗剂的设计
ACS Cent Sci. 2019 May 22;5(5):917-926. doi: 10.1021/acscentsci.9b00284. Epub 2019 Apr 11.
8
Anticancer polymers designed for killing dormant prostate cancer cells.用于杀死休眠前列腺癌细胞的抗癌聚合物。
Sci Rep. 2019 Jan 31;9(1):1096. doi: 10.1038/s41598-018-36608-5.
9
A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging.一种用于正电子发射断层扫描和荧光成像的肿瘤靶向聚合物诊疗平台。
Nanoscale. 2017 Aug 3;9(30):10906-10918. doi: 10.1039/c7nr03306k.
10
Covalent nano delivery systems for selective imaging and treatment of brain tumors.用于脑肿瘤选择性成像和治疗的共价纳米递送系统。
Adv Drug Deliv Rev. 2017 Apr;113:177-200. doi: 10.1016/j.addr.2017.06.002. Epub 2017 Jun 10.
本文引用的文献
1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.生物系统中的多价相互作用：对多价配体和抑制剂设计与应用的启示
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
Poly(-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers.聚（甲基丙烯酸-2-羟丙酯）-丙戊酸共轭物作为嵌段共聚物纳米载体
Polym Chem. 2017 Sep 14;8(34):4983-4987. doi: 10.1039/C7PY00196G. Epub 2017 Feb 22.
3
Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.聚 N-(2-羟丙基)甲基丙烯酰胺共聚物紫杉醇和吉西他滨缀合物序贯联合治疗卵巢癌。
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12181-6. doi: 10.1073/pnas.1406233111. Epub 2014 Aug 4.
4
Targeting a rare amyloidotic disease through rationally designed polymer conjugates.通过合理设计的聚合物缀合物靶向罕见的淀粉样变性疾病。
J Control Release. 2014 Mar 28;178:95-100. doi: 10.1016/j.jconrel.2014.01.019. Epub 2014 Jan 31.
5
Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.用于炎症性关节炎的纳米药物：含糖皮质激素的聚合物、胶束和脂质体的头对头比较。
ACS Nano. 2014 Jan 28;8(1):458-466. doi: 10.1021/nn4048205. Epub 2013 Dec 27.
6
Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells.骨干可降解 HPMA 共聚物吉西他滨和铂缀合物对人卵巢癌细胞的联合细胞毒性。
Eur J Pharm Biopharm. 2014 May;87(1):187-96. doi: 10.1016/j.ejpb.2013.11.008. Epub 2013 Dec 4.
7
Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.通过寡核苷酸杂交诱导细胞表面杂交纳米复合物的自组装诱导细胞凋亡。
ACS Nano. 2014 Jan 28;8(1):719-30. doi: 10.1021/nn4053827. Epub 2013 Dec 10.
8
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.通过酸可裂解键将与吡柔比星偶联的 N-(2-羟丙基)甲基丙烯酰胺共聚物进行肿瘤选择性递药的两步机制。
J Control Release. 2014 Jan 28;174:81-7. doi: 10.1016/j.jconrel.2013.11.011. Epub 2013 Nov 21.
9
Pathogenesis of pancreatic cancer: lessons from animal models.胰腺癌的发病机制：来自动物模型的经验教训。
Toxicol Pathol. 2014 Jan;42(1):217-28. doi: 10.1177/0192623313508250. Epub 2013 Oct 31.
10
Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.间隔长度会影响靶向结合多西他赛的前列腺特异性膜抗原表达前列腺癌的疗效。
J Drug Target. 2013 Dec;21(10):968-80. doi: 10.3109/1061186X.2013.833207.
Zotero 插件